Boston Trust Walden SMID Cap WASMX Fund Analysis

| Medalist Rating as of | See Boston Trust Walden Investment Hub

Morningstar’s Analysis WASMX

Will WASMX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A great SMID-cap option.

Associate Director Andrew Daniels

Andrew Daniels

Associate Director

Summary

Boston Trust Walden SMID Cap retains long-term merit despite some recent manager shuffling.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center